Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temperature-controlled Radiofrequency vs Topical Estriol for Vulvovaginal Atrophy
NCT04657536Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Randomised, open-label trial in Vulvovaginal atrophy (VVA) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Vaginal Maturation Index at 3 months and Vaginal symptoms and signs scores at 3 months. Status: unknown.
02
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT04657536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04657536.